Pyra Pharmaceutical Limited

Pyra Pharmaceutical Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U24232WB2011PLC165248 Incorporated 23 July 2011 ROC Kolkata HQ Kolkata, West Bengal, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹13,327
▲ 5% YoY
Net profit · FY 2025
₹1,637
Net margin 12.3%
EBITDA · FY 2025
₹1,637
EBITDA margin 12.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Pyra Pharmaceutical Limited

Data last updated:

Pyra Pharmaceutical Limited is a public limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 July 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB2011PLC165248.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Subir Choudhury and Ayush Poddar.

Its last annual general meeting (AGM) was held on 13 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18 Rabindra Sarani Poddar Court Gate No 1 9th Floor, Kolkata, West Bengal, India – 700001.

As per the financials filed for FY 2025, the company reported a revenue of ₹13,327, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1,637 (net margin 12.3%) and EBITDA of ₹1,637 (EBITDA margin 12.3%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 4% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232WB2011PLC165248
Registration Number 165248
Incorporation Date 23 July 2011
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 13 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Pyra Pharmaceutical Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    18 Rabindra Sarani Poddar Court Gate No 1 9th Floor, Kolkata, West Bengal, India – 700001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Pyra Pharmaceutical Limited, buy the company report.

Comprehensive company report
Pyra Pharmaceutical Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Pyra Pharmaceutical Limited

FY 2025 filings available

Pyra Pharmaceutical Limited reported revenue of ₹13,327 (up 5% YoY) for FY 2025.

Revenue · FY 2025
₹13,327 ▲ 5%
Net profit · FY 2025
₹1,637 margin 12.3%
EBITDA · FY 2025
₹1,637 margin 12.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 9%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 192%
3 years · compounded
▲ 34%
5 years · compounded
▲ 17%

Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 192% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1,637
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1,637
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin12.3%
Net Profit Margin12.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pyra Pharmaceutical Limited, buy the company report.

Board of directors of Pyra Pharmaceutical Limited

Pyra Pharmaceutical has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Subir ChoudhuryDirector23 Jul 201115 Years 3 MonthsCurrent
Ayush PoddarDirector23 Jul 201115 Years 3 MonthsCurrent
Sailesh SahalDirector13 Aug 20188 Years 2 MonthsCurrent

Auditor

Pyra Pharmaceutical Limited is audited by G BASU & CO. for the financial year 2017.

Auditor firmFinancial yearFirm registration number
G BASU & CO.FY 2017301174E

Shareholding

The shareholding of Pyra Pharmaceutical Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Pyra Pharmaceutical Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Pyra Pharmaceutical Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Pyra Pharmaceutical Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Pyra Pharmaceutical Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Sailesh Sahal ceased to be Additional Director on 30 Sep 2019.

AGM
Pyra Pharmaceutical Limited last Annual general meeting of members was held on 13 Sep 2025 as per latest MCA records.
Filing
Pyra Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Ceased
Sailesh Sahal ceased to be Additional Director.
Ceased
Devashish Poddar ceased to be Director.
Appointed
Sailesh Sahal was appointed as Director.
Appointed
Ayush Poddar was appointed as Director.
Appointed
Subir Choudhury was appointed as Director.
Incorporation
23 Jul 2011
Pyra Pharmaceutical Limited was registered on 23 Jul 2011 with Roc Kolkata & aged 15 years 3 months as per MCA records.

Frequently asked questions

Pyra Pharmaceutical is an active public limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 July 2011 (15+ years old) and is registered under CIN U24232WB2011PLC165248.

Pyra Pharmaceutical has 3 current directors:

The latest financial statements of Pyra Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 13 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Pyra Pharmaceutical is U24232WB2011PLC165248. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pyra Pharmaceutical was incorporated on 23 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kolkata.

Sailesh Sahal ceased to be Additional Director on 30 Sep 2019. Devashish Poddar ceased to be Director on 14 Aug 2018. Sailesh Sahal was appointed as Director on 13 Aug 2018. Pyra Pharmaceutical has 5 board changes on record in total.

The registered office of Pyra Pharmaceutical is at 18 Rabindra Sarani Poddar Court Gate No 1 9th Floor, Kolkata, West Bengal, India – 700001.

Pyra Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Pyra Pharmaceutical is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.

Pyra Pharmaceutical can be reached at its registered office: 18 Rabindra Sarani Poddar Court Gate No 1 9th Floor, Kolkata, West Bengal, India – 700001.